<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570374</url>
  </required_header>
  <id_info>
    <org_study_id>Oroshjalpen</org_study_id>
    <nct_id>NCT01570374</nct_id>
  </id_info>
  <brief_title>Internet-based Treatment of Generalized Anxiety Disorder</brief_title>
  <official_title>Internet-based Treatment of Generalized Anxiety Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether internet-administered cognitive behavior
      therapy is a feasible treatment for generalized anxiety disorder.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>24 hours</time_frame>
    <description>Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>6 months</time_frame>
    <description>Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>12 months</time_frame>
    <description>Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>24 months</time_frame>
    <description>Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Beck Anxiety Inventory (BAI)</measure>
    <time_frame>24 hours</time_frame>
    <description>21 item rating scale for anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Beck Anxiety Inventory (BAI)</measure>
    <time_frame>6 months</time_frame>
    <description>21 item rating scale for anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Beck Anxiety Inventory (BAI)</measure>
    <time_frame>12 months</time_frame>
    <description>21 item rating scale for anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Beck Anxiety Inventory (BAI)</measure>
    <time_frame>24 months</time_frame>
    <description>21 item rating scale for anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Quality Of Life Inventory (QOLI)</measure>
    <time_frame>24 hours</time_frame>
    <description>The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Quality Of Life Inventory (QOLI)</measure>
    <time_frame>6 months</time_frame>
    <description>The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Quality Of Life Inventory (QOLI)</measure>
    <time_frame>12 months</time_frame>
    <description>The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Quality Of Life Inventory (QOLI)</measure>
    <time_frame>24 months</time_frame>
    <description>The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>9-item depression rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)</measure>
    <time_frame>6 months</time_frame>
    <description>9-item depression rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)</measure>
    <time_frame>12 months</time_frame>
    <description>9-item depression rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)</measure>
    <time_frame>24 months</time_frame>
    <description>9-item depression rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>Weekly during treatment period</time_frame>
    <description>The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>24 hours</time_frame>
    <description>The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>6 months</time_frame>
    <description>The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>12 months</time_frame>
    <description>The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>24 months</time_frame>
    <description>The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>Weekly during treatment period</time_frame>
    <description>7-item screening form for Generalized Anxiety Disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>24 hours</time_frame>
    <description>7-item screening form for Generalized Anxiety Disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>6 months</time_frame>
    <description>7-item screening form for Generalized Anxiety Disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>12 months</time_frame>
    <description>7-item screening form for Generalized Anxiety Disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>24 months</time_frame>
    <description>7-item screening form for Generalized Anxiety Disorder.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Generalized Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>iCBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting list control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The waiting list control group initially receives no treatment, but do weekly screenings. After 9 weeks, the control group receives the same treatment as the other study arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based cognitive behavioral therapy (iCBT)</intervention_name>
    <description>9 week internet-administered, therapist-assisted, controlled-progression cognitive behavioral therapy (iCBT). Individualized and disorder-specific.</description>
    <arm_group_label>iCBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Satisfy DSM-IV criteria for generalized anxiety disorder

          -  Living in Sweden and being able to read Swedish

          -  Access to computer with internet connection

        Exclusion Criteria:

          -  Currently receiving other psychological treatment

          -  Non-stable use of psychoactive medication

          -  Deemed suicidal

          -  Deemed to suffer from other psychological disorder, e.g. psychosis, bipolarity etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Carlbring, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychology, Umeå University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychology, Umeå University</name>
      <address>
        <city>Umeå</city>
        <state>Västerbotten</state>
        <zip>90181</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <results_reference>
    <citation>Dahlin M, Andersson G, Magnusson K, Johansson T, Sjögren J, Håkansson A, Pettersson M, Kadowaki Å, Cuijpers P, Carlbring P. Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: A randomized controlled trial. Behav Res Ther. 2016 Feb;77:86-95. doi: 10.1016/j.brat.2015.12.007. Epub 2015 Dec 21.</citation>
    <PMID>26731173</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2012</study_first_submitted>
  <study_first_submitted_qc>April 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>October 31, 2016</last_update_submitted>
  <last_update_submitted_qc>October 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Per Carlbring, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cognitive behavioral therapy</keyword>
  <keyword>Internet</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Generalized anxiety disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

